FDA greenlights Amgen’s Nplate for pediatric immune thrombocytopenia

Amgen’s Nplate (romiplostim) has received US Food and Drug Administration (FDA) approval for treating pediatric patients with immune thrombocytopenia (ITP). This latest approval extends the ... Read More